BiotevsCorteva

BTMD and CTVA stock compared: price, dividend, valuation and results, from SEC filings.

Over the last year, with dividends, BTMD moved -61.9% and CTVA -7.8%. Dividend yield: BTMD 3.88%, CTVA none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BTMD$30M

    CTVA–

  • Revenue, 12 months

    BTMD$179M

    CTVA$17.7B

    CTVA is 99 times BTMD

  • Net income, 12 months

    BTMD-$1.9M

    CTVA$759M

  • Operating margin

    BTMD5.0%

    CTVA–

  • ROIC

    BTMD15.5%

    CTVA3.0%

    12.5 points apart

  • P/E

    BTMD–

    CTVA–

  • Dividend yield

    BTMD3.9%

    CTVA0.0%

    3.9 points apart

  • 5-year return

    BTMD-90.2%

    CTVA+31.0%

    121.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BTMD-90.1%

CTVA+31.0%

010020020222023202420252026
Returns by period
PeriodBTMDWith dividendsCTVAWith dividends
1 year since November 14, 2025-61.9%Price -61.9%-7.8%Price -8.7%
3 years since November 16, 2023-80.2%-41.7% a yearPrice -80.2%+32.4%+9.8% a yearPrice +28.2%
5 years since November 15, 2021-90.2%-37.1% a yearPrice -90.2%+31.0%+5.5% a yearPrice +24.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BTMDBioteCTVACorteva

Valuation

BTMDCTVA
Valuation
Price$0.96$9.04
Market value$30M–
Enterprise value (EV)$141M–
P/E––
P/E, 5-year median38.041.9
P/B––
EV/EBIT15.7–
Free cash flow yield24.7%–

Results and growth

BTMDCTVA
Results and growth
Revenue, 12 months$179M$17.7B
Net income, 12 months-$1.9M$759M
Free cash flow, 12 months$7.4M-$149M
Earnings per share, 12 months-$0.10$1.14
Revenue growth, year on year-2.5%2.9%
Revenue growth a year, past+8.4%over 4 years+4.1%over 5 years
EPS growth a year, past–+12.0%over 5 years

Margins and returns on capital

BTMDCTVA
Margins and returns on capital
Gross margin67.5%49.7%
Operating margin5.0%–
Net margin-1.1%4.3%
ROIC15.5%3.0%
ROE–3.1%

Balance sheet

BTMDCTVA
Balance sheet
Cash$8.9M$3.9B
Total debt$128M$7.4B
Net debt / EBITDA8.81.4
Interest cover–6.7×

Dividends and buybacks

BTMDCTVA
Dividends and buybacks
Dividend yield3.9%–
Dividend per share, 12 months$0.04$0.72
Dividend growth a year, past–+6.1%over 5 years
Buyback yield11.2%–
Shareholder yield15.1%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BTMD or CTVA

Didn't find what you were looking for?

Ask us
How did BTMD and CTVA stock do over the last 5 years?

Since November 15, 2021, BTMD's price moved -90.2% and CTVA's +24.5%. With dividends: BTMD -90.2% (-37.1% a year), CTVA +31.0% (+5.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, BTMD or CTVA?

The dividend yield at today's price is 3.88% for Biote and none for Corteva. Over the last twelve months they paid $0.04 and $0.72 per share.

Which has the higher profit margins, Biote or Corteva?

Over the last twelve months, the net margin was -1.1% for Biote and 4.3% for Corteva, and the operating margin 5.0% and –. Revenue was $179M and $17.7B.

Which is the better investment, Biote or Corteva?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.